Jazz Pharmaceuticals (JAZZ) Selling, General & Administrative (2010 - 2026)

Jazz Pharmaceuticals (JAZZ) Selling, General & Administrative (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 582.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 662.10 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.13 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 110.21 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 593.21 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 2,715.95
7 Royalty Pharma 33.72 Bn 35.84 Bn - 161.89 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 347.92 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 247.47 Mn
10 Jazz Pharmaceuticals 15.90 Bn 14.28 Bn 1.09 Bn 389.20 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 389.20 Mn
Mar 31, 2026 352.70 Mn
Dec 31, 2025 406.21 Mn
Sep 30, 2025 530.65 Mn
Jun 30, 2025 358.40 Mn
Mar 31, 2025 514.00 Mn
Dec 31, 2024 369.29 Mn
Sep 30, 2024 325.77 Mn
Jun 30, 2024 338.52 Mn
Mar 31, 2024 351.71 Mn
Dec 31, 2023 396.03 Mn
Sep 30, 2023 308.31 Mn
Jun 30, 2023 340.84 Mn
Mar 31, 2023 297.92 Mn
Dec 31, 2022 383.20 Mn
Sep 30, 2022 358.48 Mn
Jun 30, 2022 366.47 Mn
Mar 31, 2022 308.81 Mn
Dec 31, 2021 398.46 Mn
Sep 30, 2021 363.68 Mn